CTA-PB

Business Context and Reporting Period

This Form 8-K, filed on January 26, 1994, by E. I. du Pont de Nemours and Company (DuPont), reports fourth-quarter and full-year 1993 financial results. The filing includes an earnings press release detailing a substantial recovery from the significant losses incurred in 1992, driven by restructuring, cost reductions, and improved performance in the petroleum segment.

Key Financial Metrics

Segment Performance (Full Year 1993 Adjusted Earnings):

• Petroleum: $743 million (up 72% vs. prior year).
• Fibers: $425 million (down 11% vs. prior year).
• Chemicals: $282 million (up 2% vs. prior year).
• Polymers: $340 million (flat vs. prior year).
• Diversified Businesses: $238 million (up 35% vs. prior year).

Liquidity and Debt: Management reported a reduction in borrowings of more than $1 billion in 1993 due to aggressive working capital management and inventory reduction. Specific debt balances and cash flow figures are not explicitly detailed in the provided text beyond the reduction metric.

Material Changes Versus Prior Period

Turnaround in Profitability: The company shifted from a full-year 1992 loss of $3.9 billion to a 1993 net income of $555 million. On an adjusted basis (excluding nonrecurring items), earnings increased 25% year-over-year.

Revenue Decline: Total sales decreased 2% to $37.1 billion, primarily due to currency effects from a strong dollar and lower selling prices in international markets, despite somewhat higher volumes in core businesses.

Nonrecurring Items:

• 1993 Charges: Q4 included a net charge of $103 million ($0.15/share), primarily an accrual of $144 million for "Benlate" DF fungicide product liability claims and legal expenses. This was partially offset by a $52 million gain on the sale of Remington Arms and DuPont Canada's polyethylene business.
• 1992 Charges: The prior year included massive restructuring charges of $327 million in Q4 and significant accounting transition charges totaling $4.8 billion for the full year, which heavily distorted the 1992 net loss.

Guidance, Outlook, and Risks

Management Commentary: Chairman Edgar S. Woolard attributed the improvement to reduced fixed costs, better results in Europe, and improving U.S. economic conditions. The company plans to continue efforts to improve productivity and increase revenues to outpace global economic growth.

Risks and Contingencies:

• Product Liability: Ongoing litigation and costs related to the "Benlate" DF fungicide recall remain a material contingency, with estimates updated based on trial experiences.
• Currency Fluctuations: A strong dollar negatively impacted sales and earnings in international segments, particularly Fibers and Chemicals.
• Market Conditions: Weak economic conditions in Europe and declining prices for white pigments and non-automotive polymers pose risks to segment margins.

Investor Verification Checklist

• Benlate Liability: Verify the sufficiency of the $144 million accrual for product liability claims and the potential for future litigation costs.
• Adjusted Earnings Quality: Confirm the sustainability of the 25% adjusted earnings growth by analyzing the permanence of cost reductions versus one-time restructuring benefits.
• Currency Exposure: Assess the impact of the strong dollar on future international sales and margins, particularly in the Fibers and Chemicals segments.
• Debt Reduction: Validate the reported $1 billion reduction in borrowings and its impact on interest expense and liquidity ratios.
• Segment Mix: Review the reliance on the Petroleum segment, which drove the majority of the earnings recovery, against the underperformance in Fibers and Diversified Businesses.